Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Fibroid location linked to changes in uterine blood flow

NCT ID NCT07186257

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at how the location of uterine fibroids affects blood flow in the uterine artery. Researchers used ultrasound to measure blood flow in 185 women with fibroids and compared results based on fibroid location. They found that fibroids located within the uterine muscle (intramural) were linked to lower resistance in the artery, while other locations had different effects. The study was completed and aimed to better understand the relationship between fibroid location and blood flow.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

185 people

The number who actually took part.

Started

Oct 2024

Finished

Jun 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patients who have appointments for the outpatient clinic of the hospital

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * being older than 18 years old * accepting the transvaginal ultrasound examination and having no impediment of having transvaginal ultrasound examination * premenopausal status * giving verbal and written consent to enroll * being in the follicular phase of the menstrual cycle Exclusion Criteria: * being younger than 18 years old * pregnancy or postpartum status * postmenopausal status * being virgin * not accepting the transvaginal ultrasound examination or having an impeding condition * having a disease causing circulaiton abnormalities, cardiac diseases, or other comorbidities effecting circulation * diagnosed diabetes * taking any of the hormonal drugs (such as oral contraceptives, levonorgestrel realisng intrauterine devices) * diagnosed with any other gyneoclogical pathologies ( adenomyosis, endometriosis, adnexial masses, gynecologic malignancies, pelvic inflammatory diseases etc. ) * being in the phases of menstrual cycle other than follicular phase * diagnosis with type 2-5 and type 8 leiomyoma uteri according to the FIGO classification * having multiple uterine leiomyomas * having a uterine leiomyoma larger than 500cm3

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Leiomyoma (uterine fibroids) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bakırköy Dr Sadi Konuk Eğitim ve Araştırma Hastanesi

    Istanbul, bakırköy, 34147, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.